Robert Roebling
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
-
- Epilepsy research and treatment 9
-
- Neurological disorders and treatments 2
- Botulinum Toxin and Related Neurological Disorders 2
- Co-authors
- Holger Lerche (5 shared papers)Michaela Fritz (1 shared paper)Klaus Aktories (1 shared paper)Holger Barth (1 shared paper)Ingo Uttner (1 shared paper)Oliver Gruber (1 shared paper)Eduard Kraft (1 shared paper)Björn Steiniger‐Brach (3 shared papers)
- Journals
- Epilepsia (6 papers)Epilepsia Open (2 papers)British Journal of Clinical Pharmacology (1 paper)Epilepsy Research (1 paper)CNS Drugs (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Robert Roebling
18 papers receiving 742 citations
Peers
Comparison fields: 5 of 71
- Psychiatry and Mental health 230
- Clinical Biochemistry 93
- Cellular and Molecular Neuroscience 216
- Neurology 156
- Physiology 142
Countries citing papers authored by Robert Roebling
This map shows the geographic impact of Robert Roebling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roebling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roebling more than expected).
Fields of papers citing papers by Robert Roebling
This network shows the impact of papers produced by Robert Roebling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roebling. The network helps show where Robert Roebling may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Roebling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 295 | |
| 2 | 2010 | 111 | |
| 3 | 2009 | 79 | |
| 4 | 2002 | 68 | |
| 5 | 2020 | 62 | |
| 6 | 2012 | 37 | |
| 7 | 2020 | 21 | |
| 8 | 2011 | 20 | |
| 9 | 2019 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2023 | 10 | |
| 13 | 2009 | 5 | |
| 14 | 2009 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 0 | |
| 20 | 2023 | 0 |
About Robert Roebling
Robert Roebling is a scholar working on Psychiatry and Mental health, Neurology, Pediatrics, Perinatology and Child Health, Rheumatology and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 770 indexed citations. Recurring topics across this work include Epilepsy research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Neurological disorders and treatments (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Statistical Methods in Clinical Trials (1 paper) and Diet and metabolism studies (1 paper). The work is most often cited by research in Psychiatry and Mental health (230 citations), Clinical Biochemistry (93 citations), Cellular and Molecular Neuroscience (216 citations), Neurology (156 citations) and Physiology (142 citations). Robert Roebling has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Holger Lerche, Michaela Fritz, Klaus Aktories, Holger Barth, Ingo Uttner, Oliver Gruber, Eduard Kraft, Björn Steiniger‐Brach, Jan Kassubek and Yvonne Weber. Their work appears in journals such as Epilepsia, Epilepsia Open, British Journal of Clinical Pharmacology, Epilepsy Research and CNS Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.